Cite
Nabe Y, Kikuchi S, Kamihara Y, et al. Early complete response of primary bone marrow B-cell lymphoma treated with rituximab-based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement. Clin Case Rep. 2021;9(8):e04657doi: 10.1002/ccr3.4657.
Nabe, Y., Kikuchi, S., Kamihara, Y., Wada, A., Murakami, J., & Sato, T. (2021). Early complete response of primary bone marrow B-cell lymphoma treated with rituximab-based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement. Clinical case reports, 9(8), e04657. https://doi.org/10.1002/ccr3.4657
Nabe, Yoshimi, et al. "Early complete response of primary bone marrow B-cell lymphoma treated with rituximab-based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement." Clinical case reports vol. 9,8 (2021): e04657. doi: https://doi.org/10.1002/ccr3.4657
Nabe Y, Kikuchi S, Kamihara Y, Wada A, Murakami J, Sato T. Early complete response of primary bone marrow B-cell lymphoma treated with rituximab-based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement. Clin Case Rep. 2021 Aug 16;9(8):e04657. doi: 10.1002/ccr3.4657. eCollection 2021 Aug. PMID: 34430019; PMCID: PMC8365553.
Copy
Download .nbib